로딩 중…
지수 로딩 중…
Mesoblast Limited
MESO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
AU
$14.37+2.86%
2026-06-18
Price Chart
Mesoblast Limited+22.93%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.86B |
| Total Assets | $782M |
| Net Assets | $575M |
| Value | |
| P/B | 3.23x |
| FCF Yield | -2.90% |
| Profitability | |
| Revenue Growth | 191.39% |
| Financial Health | |
| Debt Ratio | 36.13% |
| Total Debt | $135M |
| FCF | $-54M |
| Cash | $130M |
| Current Ratio | 1.58x |
| Performance | |
| 1Y Return | 22.93% |
| 1M Return | -1.24% |
| From 52W High | -33.16% |
| 1Y MDD | -34.69% |
| Trading | |
| Volume | 124,909 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $-0.65 |
| BPS | $4.76 |